Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin.
about
Cell membrane modulation as adjuvant in cancer therapysiRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cellsPhotodynamic tumor eradication with a novel targetable photosensitizer: strong vascular effects and dependence on treatment repetition versus potentiation.Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistanceNanovehicular intracellular delivery systems.Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance.Improving intracellular doxorubicin delivery through nanoliposomes equipped with selective tumor cell membrane permeabilizing short-chain sphingolipids.Short-chain sphingolipids for enhanced cellular uptake of liposome-encapsulated amphiphilic anti-cancer drugs.
P2860
Q28078167-732633F4-B500-4AF9-8BB3-B57865C8A6FFQ33439232-CCC36AC1-763E-4C6D-9965-2139D84D80CFQ34474855-971D36D3-CC9D-4FEF-91CB-51B65C27E63AQ34478394-BA5E3055-B6E4-4B6E-9EC1-FA3F44C32C10Q36907239-B00E2A59-9203-4A19-B8FE-B12429E6C991Q37058812-06B1AA2D-B70D-42D2-A9A8-7A00E94C52D3Q38862896-20A24D93-4025-4837-89D2-0726EB63F1BDQ39153169-3241757B-BB0F-4FC6-9745-FFDE502E0EB2Q46219414-FC935412-CD85-4F42-9C6B-480C9285A869
P2860
Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Coformulated N-octanoyl-glucos ...... city of liposomal doxorubicin.
@en
type
label
Coformulated N-octanoyl-glucos ...... city of liposomal doxorubicin.
@en
prefLabel
Coformulated N-octanoyl-glucos ...... city of liposomal doxorubicin.
@en
P2093
P356
P1476
Coformulated N-octanoyl-glucos ...... icity of liposomal doxorubicin
@en
P2093
Gerben A Koning
Gert Storm
Marcel Verheij
Robert Jan Veldman
Shuraila Zerp
Stefan R Vink
Wim J van Blitterswijk
P304
P356
10.1124/JPET.105.087486
P407
P577
2005-07-22T00:00:00Z